Citadel Advisors’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.43M | Sell |
2,317,290
-1,329,619
| -36% | -$4.84M | ﹤0.01% | 1497 |
|
2025
Q1 | $7M | Buy |
3,646,909
+2,264,763
| +164% | +$4.35M | ﹤0.01% | 1505 |
|
2024
Q4 | $2.63M | Buy |
+1,382,146
| New | +$2.63M | ﹤0.01% | 2327 |
|
2024
Q3 | – | Sell |
-214,669
| Closed | -$219K | – | 5741 |
|
2024
Q2 | $219K | Buy |
214,669
+131,435
| +158% | +$134K | ﹤0.01% | 4578 |
|
2024
Q1 | $152K | Sell |
83,234
-105,360
| -56% | -$193K | ﹤0.01% | 4910 |
|
2023
Q4 | $234K | Buy |
+188,594
| New | +$234K | ﹤0.01% | 4454 |
|
2023
Q3 | – | Sell |
-965
| Closed | -$883 | – | 5835 |
|
2023
Q2 | $883 | Buy |
+965
| New | +$883 | ﹤0.01% | 5634 |
|
2023
Q1 | – | Sell |
-13,397
| Closed | -$7.73K | – | 5876 |
|
2022
Q4 | $7.73K | Sell |
13,397
-287,777
| -96% | -$166K | ﹤0.01% | 5721 |
|
2022
Q3 | $95K | Sell |
301,174
-156,129
| -34% | -$49.2K | ﹤0.01% | 5132 |
|
2022
Q2 | $162K | Buy |
457,303
+2,306
| +0.5% | +$817 | ﹤0.01% | 5085 |
|
2022
Q1 | $326K | Sell |
454,997
-110,900
| -20% | -$79.5K | ﹤0.01% | 4862 |
|
2021
Q4 | $1.28M | Buy |
565,897
+426,399
| +306% | +$964K | ﹤0.01% | 3516 |
|
2021
Q3 | $402K | Sell |
139,498
-65,222
| -32% | -$188K | ﹤0.01% | 4749 |
|
2021
Q2 | $776K | Sell |
204,720
-167,395
| -45% | -$635K | ﹤0.01% | 4296 |
|
2021
Q1 | $1.26M | Sell |
372,115
-608,146
| -62% | -$2.06M | ﹤0.01% | 3669 |
|
2020
Q4 | $2.75M | Buy |
980,261
+563,132
| +135% | +$1.58M | ﹤0.01% | 2269 |
|
2020
Q3 | $1.05M | Buy |
417,129
+368,387
| +756% | +$925K | ﹤0.01% | 2876 |
|
2020
Q2 | $662K | Sell |
48,742
-170,539
| -78% | -$2.32M | ﹤0.01% | 3215 |
|
2020
Q1 | $1.66M | Sell |
219,281
-688,939
| -76% | -$5.22M | ﹤0.01% | 2397 |
|
2019
Q4 | $5.74M | Buy |
908,220
+537,470
| +145% | +$3.4M | ﹤0.01% | 1550 |
|
2019
Q3 | $1.45M | Buy |
370,750
+268,218
| +262% | +$1.05M | ﹤0.01% | 2621 |
|
2019
Q2 | $497K | Buy |
102,532
+70,086
| +216% | +$340K | ﹤0.01% | 3537 |
|
2019
Q1 | $265K | Sell |
32,446
-1,407,296
| -98% | -$11.5M | ﹤0.01% | 3800 |
|
2018
Q4 | $7.96M | Buy |
1,439,742
+447,966
| +45% | +$2.48M | ﹤0.01% | 1139 |
|
2018
Q3 | $8.76M | Buy |
991,776
+371,440
| +60% | +$3.28M | ﹤0.01% | 1176 |
|
2018
Q2 | $6.19M | Buy |
620,336
+391,022
| +171% | +$3.9M | ﹤0.01% | 1269 |
|
2018
Q1 | $2.19M | Buy |
+229,314
| New | +$2.19M | ﹤0.01% | 1880 |
|
2017
Q4 | – | Hold |
0
| – | – | – | 3831 |
|
2017
Q3 | – | Sell |
-20,470
| Closed | -$294K | – | 3616 |
|
2017
Q2 | $294K | Sell |
20,470
-45,115
| -69% | -$648K | ﹤0.01% | 2930 |
|
2017
Q1 | $603K | Buy |
65,585
+26,289
| +67% | +$242K | ﹤0.01% | 2462 |
|
2016
Q4 | $409K | Buy |
+39,296
| New | +$409K | ﹤0.01% | 2618 |
|
2016
Q3 | – | Sell |
-25,818
| Closed | -$193K | – | 3532 |
|
2016
Q2 | $193K | Buy |
25,818
+4,699
| +22% | +$35.1K | ﹤0.01% | 2827 |
|
2016
Q1 | $190K | Buy |
+21,119
| New | +$190K | ﹤0.01% | 2729 |
|
2015
Q4 | – | Sell |
-63,802
| Closed | -$616K | – | 3874 |
|
2015
Q3 | $616K | Buy |
63,802
+55,340
| +654% | +$534K | ﹤0.01% | 2461 |
|
2015
Q2 | $87K | Buy |
+8,462
| New | +$87K | ﹤0.01% | 3302 |
|
2014
Q2 | – | Sell |
-18,448
| Closed | -$361K | – | 3433 |
|
2014
Q1 | $361K | Buy |
+18,448
| New | +$361K | ﹤0.01% | 2527 |
|